This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
HMO Industry: Bullish Near-Term Outlook Despite Coronavirus Impact
by Sapna Bagaria
Health Insurers are likely to gain from higher demand for its products and services from senior citizens and the rising incidence of illness, partially offset by the COVID-19-led fallout.
HCA Healthcare's (HCA) Earnings Miss in Q1, Decrease Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) Q1 earnings take a hit from the coronavirus outbreak inducing lower patient volumes.
The Zacks Analyst Blog Highlights: Lockheed Martin, The Travelers Companies, Sempra Energy, Centene and Sirius XM
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Lockheed Martin, The Travelers Companies, Sempra Energy, Centene and Sirius XM
5 Stocks Poised to Beat on Q1 Earnings Amid Coronavirus Woes
by Nalak Das
Despite coronavirus-induced economic disaster and stock market turmoil, five large-cap (market capital >$20 billion) stocks are poised to beat first-quarter earnings estimates this month.
UnitedHeath (UNH) Beats on Q1 Earnings, Dodges Coronavirus Curse
by Zacks Equity Research
UnitedHealth's (UNH) Q1 earnings benefit from higher contribution at both its segments, escaping the fallout from the coronavirus-led crisis.
The Zacks Analyst Blog Highlights: Centene, Anthem, Humana, Molina Healthcare and Magellan Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Centene, Anthem, Humana, Molina Healthcare and Magellan Health
The Zacks Analyst Blog Highlights: Evergy, MarketAxess, Newmont Goldcorp, Paycom Software and Centene
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Evergy, MarketAxess, Newmont Goldcorp, Paycom Software and Centene
What's in the Cards for UnitedHealth's (UNH) Q1 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) Q1 earnings results to reflect gain from increase in revenues and the effect of share buyback.
7 Health Insurers Poised to Beat Earnings Estimates in Q1
by Zacks Equity Research
Health insurers are likely to gain from a solid revenue base, attributable to higher premiums across Medicare, Medicaid plans.
S&P 500's Best Week Since 1974: 5 Winners With High Potential
by Sanghamitra Saha
The S&P 500 has seen its best week since 1974. These stocks beat the index healthily and also holds potential for future outperformance.
Centene Soars 47.8% in Six Months: Will the Rally Continue?
by Zacks Equity Research
Centene's (CNC) strategic initiatives and higher membership might aid its revenues to perk up its share price in turn.
Universal Health Continues to Bank on Segmental Benefits
by Zacks Equity Research
Universal Health (UHS) thrives on its strong Acute Care and Behavioral platform segments.
Humana (HUM) Continues to Ride on Medicare Business Momentum
by Zacks Equity Research
Humana (HUM) consistently thrives on the back of its well-performing Medicare business.
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHMM
Centene (CNC) Down 5.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Stock Market News for Mar 5, 2020
by Zacks Equity Research
Wall Street closed sharply higher on Wednesday after former vice president Joe Biden???s surprise victory in the Super Tuesday Democratic primary contests.
Centene (CNC) Reduces 2020 Earnings Estimates, Shares Slide
by Zacks Equity Research
Centene (CNC) updates its 2020 outlook that reflects its WellCare buyout and the potential Medicaid rate decrease.
Cigna Ties Up With Houston Methodist to Provide Quality Care
by Zacks Equity Research
Cigna (CI) partners Houston Methodist to provide affordable health plans to its members.
Should Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for GSEW
Healthcare Sector to Remain Volatile in 2020 Amid Elections
by Sapna Bagaria
Disparity in the regulatory policies of presidential candidates of various parties renders volatility to the healthcare sector.
Will UnitedHealth Stock Witness Volatility til the Elections?
by Sapna Bagaria
Shares of UnitedHealth (UNH) slide on Sanders' Nevada win. Volatility is likely to continue till the elections.
3 HMO 2019 Outperformers Likely to Retain Beat Streak in 2020
by Srijita Guha
HMO players are poised for growth on the back of higher revenues, membership growth, technological advancements and a solid capital position.
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHMM
Molina Healthcare's (MOH) Q4 Earnings Surpass, Decline Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q4 earnings benefit from lower expenses, partly offset by a loss of Medicaid members.
Cigna (CI) Q4 Earnings and Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Cigna (CI) Q4 results reflect revenue and membership growth on the back of Express Scripts acquisition.